NEW DELHI, Sept 2 (Reuters) - India's Ranbaxy Laboratories (RANB.BO), which has got orders from the national government to supply the generic version of Roche's (ROG.VX) anti-viral Tamiflu, used to treat the H1N1 flu, will supply 900,000 capsules initially, a spokesman told Reuters on Wednesday.

Ranbaxy is majority owned by Japan's Daiichi Sankyo (4568.T). (Reporting by Devidutta Tripathy)